TY - JOUR
T1 - High concentrations of histamine stimulate equine polymorphonuclear neutrophils to produce reactive oxygen species
AU - Benbarek, H.
AU - Mouithys-Mickalad, A.
AU - Deby-Dupont, G.
AU - Deby, C.
AU - Grülke, S.
AU - Nemmar, A.
AU - Lamy, M.
AU - Serteyn, D.
N1 - Funding Information:
Acknowledgements. This work was supported by a FRSM (Funds for Scientific and Medical Research-Belgium) grants n° 3.4556.95 and 3.4615.98.
PY - 1999
Y1 - 1999
N2 - Objective and design: Because high concentrations of histamine are locally released in inflammation, we investigated the effects of supraphysiological doses of histamine on the production of reactive oxygen species (ROS) by neutrophils. Materials and methods: Isolated equine neutrophils were activated by 10-4 to 5 x 10-3 M histamine. The production of ROS and free radicals was estimated by luminol-enhanced chemiluminescence (CL) and electron spin resonance (ESR) with spin trapping technique. In this model of histamine-stimulated neutrophils, we tested the antagonists of H1 and H2 histamine receptors, the role of Ca2+ and Mg2+, the role of staurosporine and pertussis toxin (inhibitors of protein kinase C and proteins G) and the effects of superoxide dismutase, catalase, hydroxyl radical scavengers (phenylalanine and mannitol) and N(G)-monomethyl-L-arginine (L-NMMA), inhibitor of NO-synthase. Results: Histamine (from 10-5 to 10-3 M) stimulated neutrophils to produce CL and ESR signals characterized by spin adducts of superoxide anion and/or hydroxyl radicals. The CL response was inhibited by 10-4 and 10-3 M H1 receptor antagonists (promethazine, pyrilamine, and diphenhydramine), by Ca2+ and Mg2+ depletion and by 10 nmoles staurosporine. CL was partially inhibited by pertussis toxin (4 μg/mL). The ESR signals were practically suppressed by pyrilamine (an H1 receptor antagonist) and superoxide dismutase, and partially inhibited by catalase, hydroxyl radical scavengers and L-NMMA (respectively 59, ± 30% and 68% inhibition). Conclusions: High concentrations of histamine stimulated the neutrophils to produce ROS and free radicals via H1 receptors and the NADPH-oxidase pathway.
AB - Objective and design: Because high concentrations of histamine are locally released in inflammation, we investigated the effects of supraphysiological doses of histamine on the production of reactive oxygen species (ROS) by neutrophils. Materials and methods: Isolated equine neutrophils were activated by 10-4 to 5 x 10-3 M histamine. The production of ROS and free radicals was estimated by luminol-enhanced chemiluminescence (CL) and electron spin resonance (ESR) with spin trapping technique. In this model of histamine-stimulated neutrophils, we tested the antagonists of H1 and H2 histamine receptors, the role of Ca2+ and Mg2+, the role of staurosporine and pertussis toxin (inhibitors of protein kinase C and proteins G) and the effects of superoxide dismutase, catalase, hydroxyl radical scavengers (phenylalanine and mannitol) and N(G)-monomethyl-L-arginine (L-NMMA), inhibitor of NO-synthase. Results: Histamine (from 10-5 to 10-3 M) stimulated neutrophils to produce CL and ESR signals characterized by spin adducts of superoxide anion and/or hydroxyl radicals. The CL response was inhibited by 10-4 and 10-3 M H1 receptor antagonists (promethazine, pyrilamine, and diphenhydramine), by Ca2+ and Mg2+ depletion and by 10 nmoles staurosporine. CL was partially inhibited by pertussis toxin (4 μg/mL). The ESR signals were practically suppressed by pyrilamine (an H1 receptor antagonist) and superoxide dismutase, and partially inhibited by catalase, hydroxyl radical scavengers and L-NMMA (respectively 59, ± 30% and 68% inhibition). Conclusions: High concentrations of histamine stimulated the neutrophils to produce ROS and free radicals via H1 receptors and the NADPH-oxidase pathway.
KW - Chemiluminescence
KW - Electron spin resonance
KW - Equine neutrophils
KW - Free radical
KW - Histamine
UR - http://www.scopus.com/inward/record.url?scp=0032717019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032717019&partnerID=8YFLogxK
U2 - 10.1007/s000110050509
DO - 10.1007/s000110050509
M3 - Article
C2 - 10598016
AN - SCOPUS:0032717019
SN - 1023-3830
VL - 48
SP - 594
EP - 601
JO - Inflammation Research
JF - Inflammation Research
IS - 11
ER -